EDGAR Filing Documents for 0000897204-13-000009

Form 5 - Annual statement of changes in beneficial ownership of securities:

SEC Accession No. 0000897204-13-000009

Filing Date

2013-02-14

Accepted

2013-02-14 19:18:31

Documents

Period of Report

2012-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	5
1	PRIMARY DOCUMENT	primary_doc.xml	5	25350
2	POWER OF ATTORNEY	poa.htm	EX-24	14165
	Complete submission text file	0000897204-13-000009.txt		40862

Mailing Address 18 Desbrosses Street New York NY 10013

Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000

INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENEXTRA S.P.A. VIA G. DE GRASSI, 11 MILAN L6 20124

Business Address

Type: 5 | Act: 34 | File No.: 001-35668 | Film No.: 13617031